Wednesday, December 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Riding the AI Wave: How the iShares MSCI World ETF Capitalized on Tech Dominance

Dieter Jaworski by Dieter Jaworski
November 27, 2025
in AI & Quantum Computing, ETF, Tech & Software
0
MSCI World ETF Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

The iShares MSCI World ETF (URTH) has delivered substantial returns, largely fueled by the artificial intelligence boom and the overwhelming influence of major U.S. technology corporations. Through November 2025, this $6.54 billion fund achieved an impressive 18.77% year-to-date performance. However, its substantial 72.19% allocation to U.S. equities raises questions about its true global diversification credentials.

Performance and Volatility: A Dual Narrative

Investors have been rewarded with strong results across multiple time horizons. The fund posted a 17.46% one-year return and a notable annualized three-year gain of 23.98%.

This performance comes with a caveat. A three-year standard deviation of 13.05% indicates significant price fluctuations. The price-to-earnings ratio of 25.55 suggests elevated valuations, a particular concern given the fund’s composition. On a positive note, its beta of 0.95 reveals it has been marginally less volatile than the broader U.S. market.

A Portfolio Dominated by Tech Titans

An examination of the fund’s largest holdings reveals a pronounced concentration in the technology sector. The top ten positions are overwhelmingly tech-oriented, with NVIDIA leading at 5.31%, followed by Apple (5.05%) and Microsoft (4.14%). Collectively, these three companies constitute over 14% of the entire fund.

This technological focus extends beyond pure-play tech firms:
* Amazon.com represents 2.71% of the portfolio
* Alphabet’s Class A and C shares combine for approximately 4%
* Other significant tech exposures include Meta, Tesla, and Broadcom
* JPMorgan Chase stands as the sole non-technology company among the top ten holdings

Should investors sell immediately? Or is it worth buying MSCI World ETF?

This heavy weighting proved advantageous in 2025, as NVIDIA’s AI-driven surge significantly boosted the ETF’s overall returns. Nevertheless, this sector concentration introduces substantial risk, especially considering current valuation levels.

The “World” ETF with a American Focus

Despite its global mandate, the fund’s geographical distribution is heavily skewed. U.S. companies dominate with a 72.19% share, while Japanese and British equities contribute just 5.40% and 3.56%, respectively. This allocation reflects global market capitalization rather than offering genuine geographical diversification.

The Cost Disadvantage

A notable weakness for URTH is its expense ratio. At 0.24%, the fund is significantly more expensive than competing products like the Vanguard FTSE Developed Markets ETF (VEA), which charges a mere 0.03%. This creates an annual cost disadvantage of 0.21 percentage points for investors.

From a liquidity perspective, the fund remains robust. It holds $6.54 billion in assets and trades over 400,000 shares daily. Premiums or discounts to its net asset value are typically contained within 0.08%.

Ad

MSCI World ETF Stock: Buy or Sell?! New MSCI World ETF Analysis from December 3 delivers the answer:

The latest MSCI World ETF figures speak for themselves: Urgent action needed for MSCI World ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.

MSCI World ETF: Buy or sell? Read more here...

Tags: MSCI World ETF
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Netflix Stock
Analysis

Netflix Stock: Aggressive Expansion Strategy Takes Shape

December 3, 2025
Synopsys Stock
AI & Quantum Computing

Synopsys Stock Ignites on Major Nvidia Investment

December 3, 2025
Meta Stock
AI & Quantum Computing

Meta’s Strategic Pivot: A Multi-Billion Dollar AI Gambit and Internal Overhaul

December 3, 2025
Next Post
Almonty Stock

Almonty Industries: Is the Recent Pullback a Buying Opportunity?

UBS Stock

UBS Faces Headwinds as Hedge Fund Unit Grapples with Major Auto Supplier Collapse

Hecla Mining Stock

Hecla Mining: Nevada Discovery Fuels Investor Excitement

Recommended

Capital One Stock

Major Institutions Back Capital One Despite Acquisition Costs

3 months ago
Coca-Cola Stock

Coca-Cola Stock: A Dual-Pronged Growth Strategy Takes Shape

1 week ago
Summit Therapeutics Stock

Summit Therapeutics: Clinical Data Divides Market as CEO Backs Conviction

3 months ago
SunHydrogen Stock

SunHydrogen Reaches Commercial Milestone with First Revenue

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Bionxt Solutions Secures Key Licensing Deal in Cancer Therapy Market

Strategic Moves and Sector Momentum: European Lithium Navigates Shareholder Shifts and Capital Strategy

Netflix Stock: Aggressive Expansion Strategy Takes Shape

Is Innovative Industrial Properties a Deep-Value Cannabis Play?

Is Alibaba’s Stock Dip a Strategic Entry Point?

Intellia Therapeutics Faces Critical Juncture Following Clinical Trial Death

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Faces Critical Juncture Amid Legal and Competitive Pressures

by Robert Sasse
December 3, 2025
0

The year 2025 is shaping up to be a formidable challenge for Novo Nordisk, with its share...

Ballard Power Stock

Is Ballard Power Stock Nearing an Inflection Point?

December 3, 2025
Redcare Pharmacy Stock

Redcare Pharmacy Shares Continue Their Steep Descent

December 3, 2025
Bionxt Solutions Stock

Bionxt Solutions Secures Key Licensing Deal in Cancer Therapy Market

December 3, 2025
European Lithium Stock

Strategic Moves and Sector Momentum: European Lithium Navigates Shareholder Shifts and Capital Strategy

December 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Faces Critical Juncture Amid Legal and Competitive Pressures
  • Is Ballard Power Stock Nearing an Inflection Point?
  • Redcare Pharmacy Shares Continue Their Steep Descent

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com